Trial Profile
Adjunctive Vortioxetine in Schizophrenia
Status:
Active, no longer recruiting
Phase of Trial:
Phase IV
Latest Information Update: 09 Feb 2024
Price :
$35
*
At a glance
- Drugs Vortioxetine (Primary)
- Indications Schizophrenia
- Focus Therapeutic Use
- Acronyms AVIS
- 06 Feb 2024 Planned End Date changed from 31 Dec 2023 to 1 Jun 2024.
- 18 Oct 2023 Planned End Date changed from 1 Oct 2023 to 31 Dec 2023.
- 21 Sep 2023 Planned End Date changed from 1 Sep 2023 to 1 Oct 2023.